Buy BPC-157 Capsules 500mcg x60 Online

Almost every peptide in this catalog ships as a vial for reconstitution because peptides are destroyed by gastric acid and intestinal proteases before they can be absorbed. BPC-157 (CAS 137525-51-0, a 15-residue sequence) is the notable exception, and the reason is in its origin. It is a fragment of body protection compound, a protein isolated from human gastric juice — a molecule that evolved in an environment of hydrochloric acid and pepsin. Its full name in the literature, stable gastric pentadecapeptide BPC-157, records that property: it is stable in human gastric juice for hours, where a typical peptide of similar length is degraded in minutes. That stability is what makes an oral capsule format chemically plausible rather than wishful. The mechanism at the tissue is the same as the injectable listing: upregulation of VEGFR2 driving the FAK-paxillin pathway and endothelial cell migration, nitric oxide signalling affecting local perfusion, and multi-pathway anti-inflammatory effects reported across more than thirty published studies. What differs is route, and with it the emphasis in the literature on gastrointestinal tissue.